Skip to main content
Livermore
Livermore
ZHEN

Opus Capital Group, LLC

SEC CIK
0001330325
Latest filing
Jul 31, 2026

NWBO holding history

Northwest Biotherapeutics Inc in every 13F filed by Opus Capital Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NWBO overviewAll 13F holders of NWBOFull Q2 2026 holdings

Shares (Q2 2026)
60,150
Value
$11.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NWBO by Opus Capital Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202660,150$11.0K<0.1%00.0%UnchangedHolders
Q1 202660,150$12.0K<0.1%00.0%UnchangedHolders
Q4 202560,150$14.0K<0.1%00.0%UnchangedHolders
Q3 202560,150$14.0K<0.1%00.0%UnchangedHolders
Q2 202560,150$14.0K<0.1%00.0%UnchangedHolders
Q1 202560,150$14.0K<0.1%00.0%UnchangedHolders
Q4 202460,150$17.0K<0.1%00.0%UnchangedHolders
Q3 202460,150$19.0K<0.1%00.0%UnchangedHolders
Q2 202460,150$26.0K<0.1%00.0%UnchangedHolders
Q1 202460,150$31.0K<0.1%00.0%UnchangedHolders
Q4 202360,150$42.0K<0.1%00.0%UnchangedHolders
Q3 202360,150$55.0K<0.1%00.0%UnchangedHolders
Q2 202360,150$34.0K<0.1%00.0%UnchangedHolders
Q1 202360,150$38.0K<0.1%00.0%UnchangedHolders
Q4 202260,150$47.0K<0.1%+5,000+9.1%AddedHolders
Q3 202255,150$39.0K<0.1%00.0%UnchangedHolders
Q2 202255,150$35.0K<0.1%+10,000+22.1%AddedHolders
Q1 202245,150$31.0K<0.1%00.0%UnchangedHolders
Q4 202145,150$32.0K<0.1%00.0%UnchangedHolders
Q3 202145,150$58.0K<0.1%00.0%UnchangedHolders
Q2 202145,150$66.0K<0.1%+650+1.5%AddedHolders
Q1 202144,500$66.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.